Molina Healthcare (NYSE:MOH) has received mixed ratings from 7 analysts over the past three months, with a majority being somewhat bullish. The average 12-month price target is $377.14, slightly down from the previous $377.57. Analysts have adjusted their ratings and price targets in response to market dynamics, with some lowering and others raising their expectations. Molina Healthcare has shown strong revenue growth but faces challenges with net margins. The company maintains a balanced debt approach and demonstrates strong ROE and ROA.